Patents by Inventor Ashwini Nangia

Ashwini Nangia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid forms of tyrosine kinase inhibitors, process for the preparation and their pharmaceutical composition thereof
    Patent number: 9895377
    Abstract: The present invention generally relates to solid forms of tyrosine kinase inhibitors, in particular combinations of tyrosine kinase inhibitors with anti-oxidative acids, processes for its preparation and a pharmaceutical compositions containing the same.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: February 20, 2018
    Assignee: LAURUS LABS LIMITED
    Inventors: Seeta Ramanjaneyulu Gorantla, Ashwini Nangia, Krishna Sumanth Peraka, Udaya Bhaskara Rao Khandavilli
  • SOLID FORMS OF TYROSINE KINASE INHIBITORS, PROCESS FOR THE PREPARATION AND THEIR PHARMACEUTICAL COMPOSITION THEREOF
    Publication number: 20140031352
    Abstract: The present invention generally relates to solid forms of tyrosine kinase inhibitors, in particular combinations of tyrosine kinase inhibitors with anti-oxidative acids, processes for its preparation and a pharmaceutical compositions containing the same.
    Type: Application
    Filed: July 23, 2013
    Publication date: January 30, 2014
    Applicant: Laurus Labs Private Limited
    Inventors: Seeta Ramanjaneyulu GORANTLA, Ashwini Nangia, Krishna Sumanth Peraka, Udaya Bhaskara Rao
  • Cyclopentenone derivatives for cancer therapy
    Patent number: 7179937
    Abstract: The invention relates to the use of derivatives of cyclopentenone for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds. The invention relates more specifically to the use of derivatives of cyclopentenone for the inhibition and/or prevention of cancer of the colon, pancreas, larynx, ovary, duodenum, kidney, oral cavity, prostate, lung, endothelial cells and leukemias.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: February 20, 2007
    Assignee: Dabur Research Foundation
    Inventors: Mukund K. Gurjar, Radhika D. Wakharkar, Gautam R. Desiraju, Ashwini Nangia, Jhillu Singh Yadav, Anand C. Burman, Rama Mukherjee, Hanumant Bapu Rao Borate, Srivari Chandrasekhar, Manu Jaggi, Anuo T. Singh, Kamal Kapoor, Sanjay Sarkhel, K. V. V. M. Sairam
  • Cyclopentenone derivatives for cancer therapy
    Publication number: 20030229146
    Abstract: The invention relates to the use of derivatives of cyclopentenone for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds.
    Type: Application
    Filed: December 4, 2002
    Publication date: December 11, 2003
    Applicant: DABUR RESEARCH FOUNDATION
    Inventors: Mukund K. Gurjar, Radhika D. Wakharkar, Gautam R. Desiraju, Ashwini Nangia, J. S. Yadav, Anand C. Burman, Rama Mukherjee, Hanumant Bapurao Borate, Srivari Chandrasekhar, Manu Jaggi, Anuo T. Singh, Kamal K. Kapoor, Sanjay Sarkhel, Kalapatapu V.V.M. Sairam